ASCO: Prolonged Survival in Multiple Myeloma Predicted Using Deep Sequencing

Multiparameter flow cytometry and deep sequencing were both able to accurately identify patients with multiple myeloma who were negative for minimal residual disease, a factor that was found to better predict prolonged survival compared with complete response as measured by traditional response criteria.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news